Donald L. Patrick PhD, MSPH, Laurie B. Burke RPh, MPH, Chad J. Gwaltney PhD, Nancy Kline Leidy PhD, Mona L. Martin RN, MPA, Lena Ring PhD
|
|
- Marcus Cross
- 6 years ago
- Views:
Transcription
1 Content Validity: Establishing and Reporting the Evidence in Newly-Developed Patient-Reported Outcome (PRO) Instruments for Medical Product Evaluation - Good Research Practices Donald L. Patrick PhD, MSPH, Laurie B. Burke RPh, MPH, Chad J. Gwaltney PhD, Nancy Kline Leidy PhD, Mona L. Martin RN, MPA, Lena Ring PhD Elizabeth Molsen RN Liaison to ISPOR PRO Task Force Initiatives
2 Task Force established in March Task Force Background Donald Patrick Built on previous work of a previous Task Force: Evaluating and Documenting the Content Validity of Patient- Reported Outcome Instruments to Support Medical Product Labeling and Promotional Claims in the United States: Report of the ISPOR PRO Existing Instruments & Their Modifications Task Force(Rothman et. al., 2009). Authors represent a range of perspectives on PRO instruments: academia, government, research organization, and industry. More than 50 ISPOR members submitted written comments during 2 rounds of comments, in addition to those received orally during the Atlanta ISPOR presentation.
3 ISPOR PRO GRP Task Force Reports The 3 ISPOR PRO GRP reports published in 2009 were downloaded 5,964 times from April 2010 to March This is an average of166 times per month each. Content Validity of Existing Instruments Changing Modes of Administration Translation & Linguistic Validation
4 Appreciation to Reviewers We would like to thank all the reviewers of this paper for their time in reviewing and sending helpful comments for these papers. We addressed each suggestion individually and discussed all as group.
5 Content Validity: Establishing and Reporting the Evidence in Newly-Developed Patient-Reported Outcome (PRO) Instruments for Medical Product Evaluation Good Research Practices Part I: Eliciting Concepts for a New PRO Instrument Part II: Assessing Respondent Understanding
6 Paper 1: Eliciting Concepts Five Steps 1. Determine the context of use. 2. Develop the research protocol for qualitative concept elicitation and analysis. 3. Conduct the concept elicitation interviews and focus groups. 4. Analyze the qualitative data. 5. Document concept development and elicitation methodology and results.
7 Step 1: Determine the context of use Laurie Burke Develop a hypothesized disease model based on literature, experts, and patients. Name and define the concept within the context of a clinical trial end-point model. Select and define the target population including cultural\language groups.
8 Step 1: Determine the context of use continued Make preliminary decisions on the range of instrument content and structure. Select a theoretical approach to guide qualitative methods for content validity. Develop an hypothesized conceptual framework for the proposed instrument.
9
10 Clinical Trial Endpoint Model A diagram or description of the hierarchy of hypothesized relationships among all endpoints in a clinical trial Example: Concepts Indication: Reduce asthma exacerbations Endpoints Primary: Asthma Exacerbation Secondary FEV1 Asthma symptom score
11 Context of Use A comprehensive and clear statement that describes the manner and purpose of use and plans for interpretation of a clinical outcome assessment (COA) Concept measured Target claim Target population Intrinsic and extrinsic sources of heterogeneity considered Type of treatment Type of trial (endpoint model)
12 Figure 2: Example conceptual framework for a PRO evaluating the concept of pain quality Aching Pain quality Deep pain Dull Itchy Surface pain Numb Tingling
13 Step 2: Develop research protocol for concept elicitation & analysis Chad Gwaltney Define the target sample characteristics. Clinical and demographic characteristics Sample size/saturation Select the data collection method - focus groups, individual interviews, both. Determine the setting and location for data collection. Develop the interview guide Draft, pilot, revise. Not a script stimulate discussion Draft, pilot, revise.
14 Step 3: Conduct the concept elicitation interviews & focus groups Mona Martin Obtain IRB approval. Recruit and train sites. Recruit participants; monitor sample characteristics to assure representation. Select and train interviewers. Conduct interviews implement quality control measures. Record or videotape interviews. Transcribe and clean transcripts.
15 Step 4: Analyze the qualitative data Lena Ring Analyze qualitative data according to theoretical approach used. Establish preliminary coding framework; update as data are coded. Establish coding procedures and train coders. Organize data using a qualitative research software. program Assess saturation. Interpret results.
16 Figure 3: From coding framework to coding dictionary Hypothesized Conceptual Framework CODING FRAMEWORK CODING DICTIONARY PRO Instrument Review Target Product Profile Interview Guide Starting Structure for Organizing Codes Structure Expanded to add more concepts expressed by patients during coding process Contains all codes assigned, grouped by concept, and linked to patient language (quotes) Literature Clinical Experts All Code Assignments from transcripts Patient Interview Results
17 Figure 4: Example Saturation Table for Concept Elicitation Interviews (Example) Symptom Saturation Table CONCEPT CODES Shortness of Breath Difficult to Breathe Not Enough Air Gasping Shallow/Quick Breathing Wheezing Coughing Chest Tightness Chest Pain Dizziness/Lightheadedness NUMBER OF NEW CONCEPT CODES APPEARING IN EACH TRANSCRIPT GROUP % of TOTAL NEW CONCEPT CODES (Total = 10) Transcript Group Where Concept First Appeared Transcript Group 1 (N=5 transcripts) X X X X X X X Transcript Group 2 (N=4 transcripts) X X Transcript Group 3 (N=5 transcripts) X Transcript Group 4 (N=5 transcripts) % 20% 10% 0%
18 Figure 5: Example Multi-Vectored Approach to Understanding Qualitative Data Patient language Relevance of Concept Attribute to Measure Necessary Coverage (degree of importance to patient) INTERPRETATION & MEANING Presenting the relation of qualitative results to concepts, and wording items with the most meaningful language appropriate to measurement design Essential Coverage (degree of importance clinically and to measurement strategy) Variability of occurrence Degree of Difficulty to Patient Degree of Bother to Patient
19 Step 5: Document concept development & elicitation methodology & results Donald Patrick Provide target claims and any other context for use. Describe target population. Provide hypothesized and revised disease model and any input from content experts. Provide endpoint model. Provide conceptual framework and revisions made from preliminary to revised.
20 Step 5: Document concept development & elicitation methodology & results continued Provide study methods via protocols and guides. Provide summary of results, including evidence of saturation. Provide transcripts of interviews and focus group. Track origin and derivation of concepts captured in the PRO instrument. Summarize qualitative data. Provide key references.
21 Table 4: Documentation of Concept Elicitation
22 Part II: Assessing Patient Understanding Five Steps 1. Develop items based on findings from concept elicitation. 2. Design cognitive interview process for the planned context of use. 3. Conduct cognitive interviews. 4. Make decisions to revise the PRO instrument. 5. Document cognitive interview results for evaluation of content validity.
23 Step 1: Develop items based on findings from concept elicitation Chad Gwaltney Develop criteria for item development and evaluation. Choose concepts to measure. Select recall period and modes of administration. Draft Instructions
24 Step 1: Develop items based on findings from concept elicitation continued Develop items and match to response scales Assess readability Determine order and sequence
25 Sample item criteria The item captures the concept that is intended. The item is worded in a manner consistent with the expressions used by patients. The item represents a single concept, rather than a multidimensional concept. The content of the item is appropriate for the mode of administration
26 Step 2: Design cognitive interview process for the planned context of use Nancy Kline Leidy Identify population Design cognitive interview process Develop Protocol and Cognitive Interview Guide
27 Step 3: Conduct cognitive interviews Mona Martin o Train interviewers o Train subject to think aloud o Use verbal probes o Monitor interview quality o Record and transcribe o Prepare result summaries
28 Step 4: Make decisions to revise the PRO instrument Nancy Kline Leidy Employ an iterative process. Reduce ambiguity in item language. Assess saturation. Balance respondent input with principles of item construction and decisions on conceptual framework.
29 Step 5: Document cognitive interview results for evaluation of content validity Lena Ring Complete Item Tracking Matrix including final item, final response scale, any preliminary domain assignment, description of intent of item, and patient quotes supporting item intent.
30 Figure 2: Example Item Tracking Matrix
31 Next Steps and Manuscript Submission Donald Patrick Submission to Value in Health in June. Questions or comments, please or
Task Force Background Donald Patrick. Appreciation to Reviewers. ISPOR PRO GRP Task Force Reports
Content Validity: Establishing and Reporting the Evidence in Newly-Developed Patient-Reported Outcome (PRO) Instruments for Medical Product Evaluation - Good Research Practices Donald L. Patrick PhD, MSPH,
More informationStudy Endpoint Considerations: Final PRO Guidance and Beyond
Study Endpoint Considerations: Final PRO Guidance and Beyond Laurie Burke Associate Director for Study Endpoints and Labeling OND/CDER/FDA Presented at: FIRST ANNUAL PATIENT REPORTED OUTCOMES (PRO) CONSORTIUM
More informationAddressing Content Validity of PRO Measures: The Unique Case of Rare Diseases
Disclaimer: Presentation slides from the Rare Disease Workshop Series are posted by the Kakkis EveryLife Foundation, for educational purposes only. They are for use by drug development professionals and
More informationPatient-Reported Outcomes (PROs) and the Food and Drug Administration Draft Guidance. Donald L. Patrick University of Washington
Patient-Reported Outcomes (PROs) and the Food and Drug Administration Draft Guidance Paul-Martini-Stiftung Berlin-Brandenburgische Akademie der Wissenschaften 6 March 2008 10:45 11:05 Donald L. Patrick
More informationPatient-Reported Outcomes to Support Medical Product Labeling Claims: FDA Perspective
Volume 10 Supplement 2 2007 VALUE IN HEALTH Patient-Reported Outcomes to Support Medical Product Labeling Claims: FDA Perspective Donald L. Patrick, PhD, MSPH 1, Laurie B. Burke, RPh, MPH, 2 John H. Powers,
More informationClinical Trial Endpoints from Mobile Technology: Regulatory Considerations September 29, 2016
Clinical Trial Endpoints from Mobile Technology: Regulatory Considerations September 29, 2016 Elektra J. Papadopoulos, MD, MPH Clinical Outcome Assessments Staff Office of New Drugs Center for Drug Evaluation
More informationBackground to the Task Force. Introduction
Volume 12 Number 8 2009 VALUE IN HEALTH Use of Existing Patient-Reported Outcome (PRO) Instruments and Their Modification:The ISPOR Good Research Practices for Evaluating and Documenting Content Validity
More informationPatient Reported Outcomes (PROs) Tools for Measurement of Health Related Quality of Life
Patient Reported Outcomes (PROs) Tools for Measurement of Health Related Quality of Life David Victorson, Ph.D. Assistant Professor Department of Medical Social Sciences Northwestern University Feinberg
More informationUpdate on CDER s Drug Development Tool Qualification Program
Update on CDER s Drug Development Tool Qualification Program ShaAvhree Buckman-Garner, M.D., Ph.D. Director Office of Translational Sciences Center for Drug Evaluation and Research U.S. Food and Drug Administration
More informationKen Bridges, MD Global Blood Therapeutics, South San Francisco, CA
SICKLE CELL DISEASE SEVERITY: A NEW FIT-FOR-PURPOSE MEASURE OF TREATMENT IMPACT TO SUPPORT THE CLINICAL DEVELOPMENT OF GBT440, A NOVEL AND POTENTIALLY DISEASE MODIFYING THERAPY FOR SCD Ken Bridges, MD
More informationEstimating sample size for qualitative research in clinical outcome assessment research: one size does not fit all! IP23
Estimating sample size for qualitative research in clinical outcome assessment research: one size does not fit all! IP23 Specialist Lead, Clinical Outcomes Assessment 1 Introduction to the panel Specialist
More informationMEASURING PATIENT AND OBSERVER-REPORTED OUTCOMES (PROS AND OBSROS) IN RARE DISEASE CLINICAL TRIALS - EMERGING GOOD PRACTICES TASK FORCE
MEASURING PATIENT AND OBSERVER-REPORTED OUTCOMES (PROS AND OBSROS) IN RARE DISEASE CLINICAL TRIALS - EMERGING GOOD PRACTICES TASK FORCE Outline I. Introduction: Current environment of clinical research
More informationSample Size Determination for Number of Patient Interviews When Developing a PRO Using Qualitative Research Based on the 2009 FDA PRO Guidance
Sample Size Determination for Number of Patient Interviews When Developing a PRO Using Qualitative Research Based on the 2009 FDA PRO Guidance Professor Consultant 2018 ASA Biopharmaceutical Section Regulatory-Industry
More informationConsiderations for requiring subjects to provide a response to electronic patient-reported outcome instruments
Introduction Patient-reported outcome (PRO) data play an important role in the evaluation of new medical products. PRO instruments are included in clinical trials as primary and secondary endpoints, as
More informationDevelopment of a patient-reported outcomes measure (PROM) for NASH that meets regulatory standards
Development of a patient-reported outcomes measure (PROM) for NASH that meets regulatory standards Dr. Maria-Magdalena Balp Director Health Economics & Outcomes Research Novartis Pharma AG This presentation
More informationClinician-reported Outcomes (ClinROs), Concepts and Development
Clinician-reported Outcomes (ClinROs), Concepts and Development William Lenderking, PhD, Senior Research Leader; Dennis Revicki, PhD, Senior Vice President, Outcomes Research In heathcare, there are many
More informationTesting the measurement equivalence of electronically migrated patient-reported outcome (PRO) instruments: Challenges and Solutions
Testing the measurement equivalence of electronically migrated patient-reported outcome (PRO) instruments: Challenges and Solutions Sonya Eremenco, Evidera, Inc., Bethesda, MD, USA Diane Wild, ICON, Oxford,
More informationLessons learned along the path to qualification of an IBS outcome measure*
Lessons learned along the path to qualification of an IBS outcome measure* Stephen Joel Coons, PhD Patient-Reported Outcome (PRO) Consortium Critical Path Institute IMMPACT-XX WASHINGTON, DC July 14, 2017
More informationMeasuring Respiratory Symptoms in Clinical Trials of COPD: Reliability and Validity of a Daily Diary APPENDIX
Measuring Respiratory Symptoms in Clinical Trials of COPD: Reliability and Validity of a Daily Diary APPENDIX NK Leidy, PhD 1 ; CC Sexton, PhD 1 ; PW Jones, PhD, FRCP 2 ; SM Notte, MBA 1 ; BU Monz, MD,
More informationin alphabetical order:
FORUM 1 in alphabetical order: 2 Laurie B. Burke, RPh, MPH, Founder, Lora Group, LLC, Royal Oak, MD, USA and Affiliate Associate Professor, University of Maryland School of Pharmacy Stefan Cano, PhD, CPsychol,
More informationHealth and Quality of Life Outcomes BioMed Central
Health and Quality of Life Outcomes BioMed Central Guidelines Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance U.S.
More informationUpdate on the Clinical Outcome Assessment Qualification Program and COA Compendium
Update on the Clinical Outcome Assessment Qualification Program and COA Compendium Seventh Annual PRO Consortium Workshop April 27-28, 2016 Michelle Campbell, PhD Clinical Outcomes Assessment Staff (COA
More informationSAMPLE SIZE, GROUNDED THEORY, AND SATURATION IN COA DEVELOPMENT. Guidance for Industry: Sample size
SAMPLE SIZE, GROUNDED THEORY, AND SATURATION IN COA DEVELOPMENT Kathryn E. Lasch, PhD Pharmerit International Executive Director, PRO/COA and Qualitative Research May 23, 2018 ISPOR 2018 Baltimore 1 Guidance
More informationEducational Program on Patient-Reported Outcomes (PROs) in Clinical Trials
SEMINAR May 23, 2003 09:00-16:45 pm INAMI, 211 Tervueren Av, BRUSSELS Educational Program on Patient-Reported Outcomes (PROs) in Clinical Trials Facilitators Catherine Acquadro, Olivier Chassany Introductions
More informationDeveloping a Pediatric COA Measurement Strategy A Case Study in Asthma
Developing a Pediatric COA Measurement Strategy A Case Study in Asthma FIFTH ANNUAL PATIENT-REPORTED OUTCOME (PRO) CONSORTIUM WORKSHOP April 29-30, 2014 Silver Spring, MD Co-sponsored by Disclaimer The
More informationSECOND ANNUAL PATIENT-REPORTED OUTCOME (PRO) CONSORTIUM WORKSHOP
SECOND ANNUAL PATIENT-REPORTED OUTCOME (PRO) CONSORTIUM WORKSHOP March 15, 2011 Silver Spring, MD Co-sponsored by To Combine or Not Combine: Individual Symptom Scores Versus Summary Scores Moderator: Margaret
More informationNHC Webinar Series on Clinical Outcome Assessments. Patient-Reported Outcomes and Patient-Centered Outcomes: Is There a Difference?
NHC Webinar Series on Clinical Outcome Assessments Patient-Reported Outcomes and Patient-Centered Outcomes: Is There a Difference? NOVEMBER 7, 2018 Outline Why are we having this webinar? Introduction
More informationQOL-CI: Development & Clinical U7lity of a Pediatric Quality of Life Instrument
QOL-CI: Development & Clinical U7lity of a Pediatric Quality of Life Instrument Ive$e Cejas, PhD Department of Otolaryngology University Of Miami 3/8/18 Conflict of Interest AG Bell Board of Directors
More informationPediatrics Milestones and Meaningful Assessment Translating the Pediatrics Milestones into Assessment Items for use in the Clinical Setting
Pediatrics Milestones and Meaningful Assessment Translating the Pediatrics Milestones into Assessment Items for use in the Clinical Setting Ann Burke Susan Guralnick Patty Hicks Jeanine Ronan Dan Schumacher
More informationMigrating a PRO Instrument. Presented by: Serge Bodart (Biomedical Systems) and Alisandra Johnson (Bracket)
Migrating a PRO Instrument Presented by: Serge Bodart (Biomedical Systems) and Alisandra Johnson (Bracket) Presenter Biographies Serge Bodart is currently based in Montreal, Canada. He has been involved
More informationFDA s GREAT Workshop. Industry Perspective: Development Activities Towards Phase 3 Endpoints. September 19, 2012
FDA s GREAT Workshop Industry Perspective: Development Activities Towards Phase 3 Endpoints Malcolm Hill, Pharm.D. Meritage Pharma, Inc. San Diego, CA 09/19/12 1 September 19, 2012 Presentation Overview
More informationDisclaimer. ISPOR 22 nd Annual International Meeting May 24, 2017 Boston, Massachusetts, USA
A Multi-Stakeholder Collaborative Approach to Developing a Patient-Reported Outcome (PRO) Measure for FDA Drug Development Tool Qualification: The PRO Consortium s Depression Working Group Experience ISPOR
More informationUnderstanding and measuring symptoms and health status in asthma COPD overlap: content validity of the EXACT and SGRQ
Nelsen et al. Journal of Patient-Reported Outcomes (2018) 2:18 https://doi.org/10.1186/s41687-018-0038-5 Journal of Patient- Reported Outcomes RESEARCH Open Access Understanding and measuring symptoms
More informationAssessing Consumer Responses to RRP: Experience at PMI in Developing Fit-for-Purpose Self-Report Instruments
Assessing Consumer Responses to RRP: Experience at PMI in Developing Fit-for-Purpose Self-Report Instruments C. Chrea, E. Spies, E. Afolalu, N. Mainy, S. Gallot, P. Binggeli, E. Clerc, R. Weitkunat PMI
More informationJournal of Patient- Reported Outcomes. Colleen A. McHorney 1*, Mark E. Bensink 2, Laurie B. Burke 3, Vasily Belozeroff 2 and Chad Gwaltney 4,5
McHorney et al. Journal of Patient-Reported Outcomes (2018) 2:6 DOI 10.1186/s41687-018-0029-6 Journal of Patient- Reported Outcomes RESEARCH Open Access Development and psychometric validation of the Nausea/Vomiting
More informationSample size for pre-tests of questionnaires. PERNEGER, Thomas, et al. Abstract
Article Sample size for pre-tests of questionnaires PERNEGER, Thomas, et al. Abstract To provide guidance regarding the desirable size of pre-tests of psychometric questionnaires, when the purpose of the
More informationThe Origins and Promise of PROMIS Patient Reported Outcomes Measurement Information System
The Origins and Promise of PROMIS Patient Reported Outcomes Measurement Information System Gene A. Kallenberg, MD Professor and Chief, Division of Family Medicine Director, UCSD Center for Integrative
More informationFundamental Concepts for Using Diagnostic Classification Models. Section #2 NCME 2016 Training Session. NCME 2016 Training Session: Section 2
Fundamental Concepts for Using Diagnostic Classification Models Section #2 NCME 2016 Training Session NCME 2016 Training Session: Section 2 Lecture Overview Nature of attributes What s in a name? Grain
More informationHealth Economics & Decision Science (HEDS) Discussion Paper Series
School of Health And Related Research Health Economics & Decision Science (HEDS) Discussion Paper Series Understanding the experience and impact of living with a vascular condition from the patients perspective:
More informationOutpatient Guideline for the Diagnosis and Management of Asthma
Outpatient Guideline for the Diagnosis and Management of Asthma Initial Visit Follow-Up Visits See page 2 Asthma Diagnosis See page 3 Classifying Asthma Severity and Initiating Treatment See pages 2 and
More informationIntroducing the OWLQOL and WRSM Instruments
Introducing the OWLQOL and WRSM Instruments Previously developed weight-specific Patient-Reported-Outcome measures (PROs) were either developed for application to more severely obese populations, or without
More informationDevelopment of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): A Patient-Reported Outcome (PRO) Measurevhe_
Volume 13 Number 8 2010 VALUE IN HEALTH Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): A Patient-Reported Outcome (PRO) Measurevhe_772 965..975 Nancy Kline Leidy,
More informationVERDIN MANUSCRIPT REVIEW HISTORY REVISION NOTES FROM AUTHORS (ROUND 2)
1 VERDIN MANUSCRIPT REVIEW HISTORY REVISION NOTES FROM AUTHORS (ROUND 2) Thank you for providing us with the opportunity to revise our paper. We have revised the manuscript according to the editors and
More informationA Comparison of Deaf/Hard of Hearing and Hearing Young Adults Responses to a Health Risk Behavior Survey
A Comparison of Deaf/Hard of Hearing and Hearing Young Adults Responses to a Health Risk Behavior Survey Tamala David, MPA, MS, FNP Doctoral Dissertation Defense University of Rochester School of Nursing
More informationInvestigator Initiated Study Proposal Form
Please submit completed form to IISReview@KCI1.com Date Submitted Name & Title Institution Address Phone Number Email Address Principal Investigator / Institution YES NO Multi Center Study Acelity Product(s)
More informationCOSMIN methodology for assessing the content validity of PROMs. User manual
COSMIN methodology for assessing the content validity of PROMs User manual version 1.0 Caroline B Terwee Cecilia AC Prinsen Alessandro Chiarotto Henrica CW de Vet Lex M Bouter Jordi Alonso Marjan J Westerman
More informationPatient Reported Outcomes
Date Patient Reported Outcomes Presented by: Ari Gnanasakthy RTI Health Solutions 9 th Feb 2015 RTI Health Solutions Research Triangle Park, NC, USA Ann Arbor, MI, USA Barcelona, Spain Ljungskile, Sweden
More informationPEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Ball State University
PEER REVIEW HISTORY BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (see an example) and are provided with free text boxes to
More informationResearch Plan And Design
Research Plan And Design By Dr. Achmad Nizar Hidayanto Information Management Lab Faculty of Computer Science Universitas Indonesia Salemba, 1 Agustus 2017 Research - Defined The process of gathering information
More informationQuestionnaire Translation
Dr Wan Nor Arifin Unit of Biostatistics and Research Methodology, Universiti Sains Malaysia. wnarifin@usm.my Wan Nor Arifin, 2017. by Wan Nor Arifin is licensed under the Creative Commons Attribution-
More informationIntroduction. Activities undertaken 13/10/2015. Qualitative Data Analysis. CSHG Hotel Management School of Galicia
Qualitative Data CSHG Hotel Management School of Galicia Features Activities Undertaken Strategies Analytical Aids Introduction Qualitative research is concerned with the production and analysis of texts
More informationQualitative Methods and Patient Reported Outcome Measures. Susan C Pitt, MD, MPHS Assistant Professor of Surgery University of Wisconsin
Qualitative Methods and Patient Reported Outcome Measures Susan C Pitt, MD, MPHS Assistant Professor of Surgery University of Wisconsin Disclosures None Overview What is it? When is it useful? Why do it?
More informationThinking with the End in Mind: From COA Instrument to Endpoint
Thinking with the End in Mind: From COA Instrument to Endpoint SIXTH ANNUAL PATIENT-REPORTED OUTCOME CONSORTIUM WORKSHOP April 29-30, 2015 Silver Spring, MD Disclaimer The views and opinions expressed
More informationAssessing Cultural Competency from the Patient s Perspective: The CAHPS Cultural Competency (CC) Item Set
Assessing Cultural Competency from the Patient s Perspective: The CAHPS Cultural Competency (CC) Item Set Robert Weech-Maldonado Department of Health Services Administration University of Alabama at Birmingham
More informationIncorporation of Imaging-Based Functional Assessment Procedures into the DICOM Standard Draft version 0.1 7/27/2011
Incorporation of Imaging-Based Functional Assessment Procedures into the DICOM Standard Draft version 0.1 7/27/2011 I. Purpose Drawing from the profile development of the QIBA-fMRI Technical Committee,
More informationMethodological Considerations in Using Patient Reported Measures in Dialysis Clinics. Acknowledgements
Methodological Considerations in Using Patient Reported Measures in Dialysis Clinics John D Peipert Ron D Hays Acknowledgements Funding for this work provided by the Kidney Care Quality Alliance 1 Patient
More informationAbstract. Key words: bias, culture, Five-Factor Model, language, NEO-PI-R, NEO-PI-3, personality, South Africa
Dedication I dedicate this research to my parents who have supported me throughout my university career. Without their emotional and financial support, none of my academic accolades could have been possible.
More informationLiteracy through Filmmaking: An interactive classroom activity
Literacy through Filmmaking: An interactive classroom activity Learning Objective(s): To explain at least 3 benefits of film making, its impact on literacy and its capacity to facilitate positive interactions
More informationTable of Contents. Preface to the third edition xiii. Preface to the second edition xv. Preface to the fi rst edition xvii. List of abbreviations xix
Table of Contents Preface to the third edition xiii Preface to the second edition xv Preface to the fi rst edition xvii List of abbreviations xix PART 1 Developing and Validating Instruments for Assessing
More informationTable of Contents. Clinical Outcome Assessments (COAs): A Conceptual Foundation
Clinical Outcome Assessments (COAs): A Conceptual Foundation Authors*: Walton MK(1), Powers JH(3), Hobart J, Patrick DL, Marquis P, Vamvakas, S(2), Isaac, M(2), Papadopoulos, E(1), Slagle, AF(1), Piault
More informationDRAFT (Final) Concept Paper On choosing appropriate estimands and defining sensitivity analyses in confirmatory clinical trials
DRAFT (Final) Concept Paper On choosing appropriate estimands and defining sensitivity analyses in confirmatory clinical trials EFSPI Comments Page General Priority (H/M/L) Comment The concept to develop
More informationTitle: Identifying work ability promoting factors for home care aides and assistant nurses
Author's response to reviews Title: Identifying work ability promoting factors for home care aides and assistant nurses Authors: Agneta Larsson (agneta.larsson@ltu.se) Lena Karlqvist (lena.karlqvist@ltu.se)
More informationCreating a Child Self-Report Measure of Adverse Events Related to Cancer Treatment; Providing a Voice for the Child
Creating a Child Self-Report Measure of Adverse Events Related to Cancer Treatment; Providing a Voice for the Child Casey Hooke, PhD, RN, PCNS, CPON University of Minnesota School of Nursing Pamela Hinds,
More informationSoftware as a Medical Device (SaMD)
Software as a Medical Device (SaMD) Clinical Evaluation IMDRF/SaMD WG (WD2)/N41R1: 2016 Bakul Patel, USA FDA Chair SaMD Working Group Scope NWIE Proposal - Software as a Medical Device (SaMD): Clinical
More informationImportant Issues in Patient Reported Outcomes (PRO) Research
Important Issues in Patient Reported Outcomes (PRO) Research Feb. 16, 2001 Organized by The Harmonization Coordination Committee Representing European Regulatory Issues on Quality-of of-life Assessment
More informationIntroduction. 1.1 Facets of Measurement
1 Introduction This chapter introduces the basic idea of many-facet Rasch measurement. Three examples of assessment procedures taken from the field of language testing illustrate its context of application.
More informationWhat is a Special Interest Group (SIG)?
PATIENT REPORTED OUTCOMES RESEARCH SPECIAL INTEREST GROUP Open Meeting 20 th Annual European Congress November 6, 2017 Glasgow, Scotland What is a Special Interest Group (SIG)? Member-driven group interested
More informationOBSERVER-REPORTED OUTCOMES IN CLINICAL TRIALS: CHALLENGES AND SOLUTIONS
OBSERVER-REPORTED OUTCOMES IN CLINICAL TRIALS: CHALLENGES AND SOLUTIONS Donald L. Patrick, PhD, MSPH, Professor, University of Washington, Seattle, WA, USA Rob Arbuckle, MSc, Director, Endpoint Development
More informationMethodological Issues in Measuring the Development of Character
Methodological Issues in Measuring the Development of Character Noel A. Card Department of Human Development and Family Studies College of Liberal Arts and Sciences Supported by a grant from the John Templeton
More informationResearch design. Neurodiversity. I praise you because I am fearfully and wonderfully made; your works are wonderful, I know that full well.
Learner characteristics and cognitive profile of students with autism (ASD) A framework of thinking, memory and learning ACHEA: 19 August 2017 Nola Norris: nolan@morling.edu.au I praise you because I am
More informationThe Research Roadmap Checklist
1/5 The Research Roadmap Checklist Version: December 1, 2007 All enquires to bwhitworth@acm.org This checklist is at http://brianwhitworth.com/researchchecklist.pdf The element details are explained at
More informationDevelopment of the Chronic Obstructive Pulmonary Disease Morning Symptom Diary (COPD-MSD)
University of Kentucky UKnowledge Preventive Medicine and Environmental Health Faculty Publications Preventive Medicine and Environmental Health 7-16-2016 Development of the Chronic Obstructive Pulmonary
More informationAn Approach to Outcome Measure Development: A Regulatory Perspective
An Approach to Outcome Measure Development: A Regulatory Perspective EMA Workshop on Alzheimer s disease November 24, 2014 Elektra J. Papadopoulos, MD, MPH Study Endpoints Team Study Endpoints and Labeling
More informationProgress from the Patient-Centered Outcomes Research Institute (PCORI)
Progress from the Patient-Centered Outcomes Research Institute (PCORI) Anne Beal, Chief Operating Officer of the Patient-Centered Outcomes Research Institute Sharon-Lise Normand, Vice Chair, Methodology
More informationResearch Questions and Survey Development
Research Questions and Survey Development R. Eric Heidel, PhD Associate Professor of Biostatistics Department of Surgery University of Tennessee Graduate School of Medicine Research Questions 1 Research
More informationSemantic Alignment between ICD-11 and SNOMED-CT. By Marcie Wright RHIA, CHDA, CCS
Semantic Alignment between ICD-11 and SNOMED-CT By Marcie Wright RHIA, CHDA, CCS World Health Organization (WHO) owns and publishes the International Classification of Diseases (ICD) WHO was entrusted
More informationWork, Employment, and Industrial Relations Theory Spring 2008
MIT OpenCourseWare http://ocw.mit.edu 15.676 Work, Employment, and Industrial Relations Theory Spring 2008 For information about citing these materials or our Terms of Use, visit: http://ocw.mit.edu/terms.
More informationUtility of an Early Case Capture Pediatric Cancer Registry
Utility of an Early Case Capture Pediatric Cancer Registry Mary Puckett, PhD Epidemic Intelligence Service Officer Comprehensive Cancer Control Branch National Center for Chronic Disease Prevention and
More informationTHE QUALITATIVE TRADITION: A COMPLIMENTARY PARADIGM FOR RESEARCH IN ECONOMIC EDUCATION
23 THE QUALITATIVE TRADITION: A COMPLIMENTARY PARADIGM FOR RESEARCH IN ECONOMIC EDUCATION George Langelett, South Dakota State University ABSTRACT The qualitative tradition provides an alternative approach
More informationBackground. 2 5/30/2017 Company Confidential 2015 Eli Lilly and Company
May 2017 Estimating the effects of patient-reported outcome (PRO) diarrhea and pain measures on PRO fatigue: data analysis from a phase 2 study of abemaciclib monotherapy, a CDK4 and CDK6 inhibitor, in
More informationResearch Design. Source: John W. Creswell RESEARCH DESIGN. Qualitative, Quantitative, and Mixed Methods Approaches Third Edition
Research Design Source: John W. Creswell RESEARCH DESIGN Qualitative, Quantitative, and Mixed Methods Approaches Third Edition The Three Types of Designs Three types Qualitative research Quantitative research
More informationFDA SUMMARY OF SAFETY AND EFFECTIVENESS DATA (SSED) CLINICAL SECTION CHECKLIST OFFICE OF DEVICE EVALUATION
FDA SUMMARY OF SAFETY AND EFFECTIVENESS DATA (SSED) CLINICAL SECTION CHECKLIST OFFICE OF DEVICE EVALUATION Note to FDA PMA Reviewers: The Summary of Safety and Effectiveness (SSED) is a document mandated
More informationPEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Veronika Williams University of Oxford, UK 07-Dec-2015
PEER REVIEW HISTORY BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf)
More informationClinical Trial Exit Interviews
Clinical Trial Exit Interviews Presented at the Clinical Outcome Assessments: Establishing and Interpreting Meaningful Within-Patient Change Meeting The Duke-Margolis Center for Health Policy, Washington,
More informationTACKLING WITH REVIEWER S COMMENTS:
TACKLING WITH REVIEWER S COMMENTS: Comment (a): The abstract of the research paper does not provide a bird s eye view (snapshot view) of what is being discussed throughout the paper. The reader is likely
More informationNCI CIRB Independent Model studies is described herein.
Review for Studies Approved by the Independent Model National Cancer Institute (NCI) Pediatric Central Institutional (Formerly entitled Facilitated IRB Review for Studies Approved by the National Cancer
More informationHareendran et al. Health and Quality of Life Outcomes (2017) 15:224 DOI /s
Hareendran et al. Health and Quality of Life Outcomes (2017) 15:224 DOI 10.1186/s12955-017-0799-1 RESEARCH Open Access Development and exploration of the content validity of a patient-reported outcome
More informationFDA issues long-awaited final guidance on when a device modification requires a new 510(k)
FDA issues long-awaited final guidance on when a device modification requires a new 510(k) November 2, 2017 Six years after its first attempt to update its 20-year-old guidelines for when modifications
More informationVaccine Acceptance in Two Middle Income Countries: The Impact of Attitudes on Vaccine Safety
Vaccine Acceptance in Two Middle Income Countries: The Impact of Attitudes on Vaccine Safety Sarah Appeadu Mentor: Dr. Kristen Feemster MD, MPH, MSHP August 14, 2014 Objectives Project Background and Significance
More informationTRANSLATING RESEARCH INTO PRACTICE
TRANSLATING RESEARCH INTO PRACTICE New York University Tbilisi, July 15-19, 2013 Allison Squires, PhD, RN Adam Sirois, MPH SESSION 2: QUESTIONS, CONCEPTS, & THEORIES Goals for Session t1 Describe the characteristics
More informationIssues in Clinical Measurement
Issues in Clinical Measurement MERMAID Series January 15, 2016 Galen E. Switzer, PhD Clinical and Translational Science Institute University of Pittsburgh What is Measurement? observation of people, clinical
More informationHSPC/IRB Description of Research Form (For research projects involving human participants)
HSPC/IRB Description of Research Form (For research projects involving human participants) This form is to be completed by the Principal Investigator (P.I.) of the research project being submitted to the
More informationQuality of Life. The assessment, analysis and reporting of patient-reported outcomes. Third Edition
Quality of Life The assessment, analysis and reporting of patient-reported outcomes Third Edition PETER M. FAYERS Institute of Applied Health Sciences, University ofaberdeen School of Medicine and Dentistry,
More informationANNEX A. STATEMENT OF WORK Task Authorization (TA) 22 FOR SUB CONTRACT WITH CIMVHR
1. NUMBER TITLE OF TASK AUTHORIZATION 1.1 TA 22 A pilot study to understand how equine-assisted therapy may assist Veterans in living with mental health conditions. 2. VALIDATION OF SCOPE OF CONTRACT 2.1
More informationCognitive testing. Quality assurance of the survey. Ăirts Briăis Luxembourg, 13 May, 2009
RIGA STRADINS UNIVERSITY Department of Public Health and Epidemiology Cognitive testing Quality assurance of the survey Ăirts Briăis Luxembourg, 13 May, 2009 Aim of a survey To obtain information which
More informationRecommendations on Evidence Needed to Support Measurement Equivalence between Electronic and
Recommendations on Evidence Needed to Support Measurement Equivalence between Electronic and Paper-based Patient-Reported Outcome (PRO) Measures: ISPOR epro Good Research Practices Task Force Report Stephen
More informationChapter 1 A Cultural Approach to Child Development
Child Development A Cultural Approach Chapter 1 A Cultural Approach to Child Development Learning Objectives (1 of 4) 1.4 Apply information about human evolution to how child development takes place today.
More informationCulture & Survey Measurement. Timothy Johnson Survey Research Laboratory University of Illinois at Chicago
Culture & Survey Measurement Timothy Johnson Survey Research Laboratory University of Illinois at Chicago What is culture? It is the collective programming of the mind which distinguishes the members of
More informationPATIENT REPORTED OUTCOMES
Introduction to Clinical Research: A Two-week Intensive Course PATIENT REPORTED OUTCOMES Albert W. Wu, MD, MPH Overview 1. Importance of patient perspective 2. Definitions 3. Key concepts to measure as
More informationSEMINAR ON SERVICE MARKETING
SEMINAR ON SERVICE MARKETING Tracy Mary - Nancy LOGO John O. Summers Indiana University Guidelines for Conducting Research and Publishing in Marketing: From Conceptualization through the Review Process
More information